Bill Lundberg

Director

Bill Lundberg is President and CEO at Merus, a leading oncology biotechnology company. He was previously Chief Scientific Officer at CRISPR Therapeutics, as well as Vice President and Head of Translational Medicine at Alexion Pharmaceuticals, where he was responsible for R&D from discovery to clinical proof-of-concept. Bill previously held senio...

Roles at Q32 Bio

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.